台股 » 個股 » 國光生 » 籌碼相關 » 券商分點績效

國光生

(4142)
可現股當沖
  • 股價
    28.10
  • 漲跌
    ▼0.15
  • 漲幅
    -0.53%
  • 成交量
    739
  • 產業
    上市 生技醫療類股
  • 633人加入追蹤

    立即追蹤

  • 本地時間:14:30

     
國光生 (4142)籌碼相關-券商分點績效/獲利分析
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

«前一日     2024/04/13 ~ 2024/04/27     後一日»

券商獲利排行 - 2024/04/13 ~ 2024/04/27

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  2.80%1,715.91,7096.95502,1471,59728.528.129.228.1
  5.70%32943.6285.410622612025.525.425.828.1
  3.35%190.231.5158.61382107227.12727.428.1
  5.82%135.29.9125.28287526.726.628.628.1
  4.75%129.366.163.3-60359528.627.329.228.1
  3.15%126.9115.411.4451429728.327.82928.1
  10.59%115.6115.60039392826.529.428.1
  5.62%111.420.590.9-52146729.628.329.828.1
  6.75%103.456.147.232562427.326.62928.1
  2.96%103.2100.42.8-1311112527.927.428.328.1
  6.53%88.554.733.820503027.126.428.228.1
  4.23%82.565.417.1-24456928.227.428.828.1
  3.19%7864.513.6-54348827.826.528.428.1
  2.56%77.963.514.41211210027.226.927.528.1
  7.58%77.625.552.2-2963529.325.729.928.1
  3.91%76.118.957.261711027.427.229.128.1
  4.27%74.64925.6-37256228.226.828.828.1
  8.01%74.245.428.8-1616322927.129.928.1
  1.35%72.1072.1-188018828.5028.528.1
  2.98%70.512.558-63198228.928.42928.1
  1.40%69.80.169.7-1314217428.628.628.628.1
  3.57%67.815.951.9-6066628.726.32928.1
  10.88%67.564.62.92222028.226.729.928.1
  4.31%67.18.858.3-41115329.328.729.528.1
  6.21%6742.124.9-22153828.426.429.228.1
  5.06%62.937.92524452127.627.128.928.1
  2.78%58.649.29.4-21547528.227.628.528.1
  5.93%57.627.530.118361826.926.42828.1
  1.91%57.259-1.8-179110827.727.32828.1
  3.06%5632.223.9-48176528.226.728.628.1
  4.22%5420.933.1-24194429.128.329.428.1
  8.44%52.913.739.11524826.125.727.428.1
  0.81%51.488.1-36.7-11611323027.52727.828.1
  5.55%50.33515.311332127.526.828.528.1
  1.75%4955-5.939985928.628.329.228.1
  3.49%4821.126.929502127.527.228.228.1
  3.30%46.127.418.719513227.427.12828.1
  3.92%45.115.329.8-29104028.827.629.128.1
  4.33%42.636.26.5-10253528.127.328.828.1
  5.80%41.729.512.36272126.726.127.528.1
  2.60%41.713.328.445581327.727.528.528.1
  3.39%41.331.59.8-15284328.327.628.828.1
  3.09%41.140.40.8-7414827.827.228.228.1
  2.91%39.7039.75050027.327.3028.1
  9.44%39.439.400151527.826.529.128.1
  2.71%38.419.918.431512027.827.528.528.1
  3.74%38.317.920.324371327.627.328.628.1
  4.24%37.324.412.912322027.52728.228.1
  4.60%36.435.60.80272828.327.628.928.1
  1.78%36.329.76.66756927.22727.428.1

券商虧損排行 - 2024/04/13 ~ 2024/04/27

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  -2.73%-447.26.1-453.3-5514960027.327.227.328.1
  -7.62%-416-67.2-348.8-1723420726.428.126.128.1
  -3.49%-256.5-163.8-92.7-7819026927.327.826.928.1
  -2.35%-207.6-39-168.6-16216432627.127.327.128.1
  -6.25%-196.7-188.8-7.9-129911128.329.327.428.1
  -5.43%-177.3-8-169.3104110629.729.728.428.1
  -6.27%-175.6-171.7-3.95100952828.927.128.1
  -5.76%-145.9-6.1-139.7-9329526.729.726.628.1
  -2.47%-144.6-104.5-40.1-2818921726.927.226.728.1
  -5.82%-124.2-27.1-97.1-57228026.727.726.428.1
  -5.32%-122.2-111.7-10.41682662828.827.128.1
  -7.03%-107.6-64.6-43-28285627.328.926.628.1
  -2.03%-107.1-41.9-65.3-1335719027.828.327.628.1
  -3.27%-99.2-29.8-69.3-882211027.528.727.328.1
  -4.91%-86.8-73.3-13.5-11526427.628.42728.1
  -0.81%-81.7-47.4-34.32763588228.128.227.628.1
  -2.94%-80.8-79.8-19999027.828.227.328.1
  -6.39%-80.3-79.3-10444527.928.927.128.1
  -4.89%-80.1-72.5-7.65575128.729.427.928.1
  -3.45%-80-82.52.5486822727.526.528.1
  -4.93%-78.4-75.4-36575127.928.627.128.1
  -8.79%-77.8-59.6-18.2-628342627.225.128.1
  -6.09%-77.3-11.2-66.13943429.629.82728.1
  -6.53%-62.9-59.4-3.53343128.429.327.428.1
  -4.92%-62.8-19.5-43.33344102929.427.428.1
  -4.00%-62.4-63.91.513574427.42826.528.1
  -1.84%-61.9-43.1-18.8-635612028.128.627.828.1
  -5.34%-59-46.1-12.914392528.32927.228.1
  -4.39%-59-40.3-18.7-16334927.428.226.928.1
  -2.13%-56.51.8-58.3-85129727.427.327.428.1
  -5.71%-51.2-50.5-0.7132312828.827.228.1
  -6.89%-49.3-40.3-8.9-6202627.528.626.628.1
  -10.42%-46-4600161627.62926.228.1
  -5.71%-45.3-1.1-44.2-2643026.426.726.428.1
  -3.40%-45.3-33.9-11.4946372929.428.528.1
  -3.06%-44.9-1.7-43.2-4595427.227.327.128.1
  -9.23%-43.9-17.7-26.2-1071826.428.225.728.1
  -2.98%-43.6-12.6-3138511328.728.927.928.1
  -7.26%-43.6-42.4-1.2-2192128.629.727.528.1
  -4.02%-43.4-24-19.4-21173927.628.627.228.1
  -2.05%-43.2-16.8-26.4-48287627.728.227.628.1
  -5.14%-42-40.5-1.5-1293027.22826.628.1
  -6.75%-41.3-11-30.2-1672326.627.826.228.1
  -1.76%-41.1-43.32.1-28548228.52928.228.1
  -4.63%-40.5-38.9-1.51312928.228.927.528.1
  -3.65%-39.1-32.1-711382728.228.727.628.1
  -2.31%-38.1-10.4-27.7-23376127.127.226.928.1
  -4.59%-36.8-18.9-17.918281028.629.127.228.1
  -6.66%-36-7.3-28.7-11102125.726.225.528.1
  -2.45%-35.8-9.2-26.636511528.728.828.228.1
國光生去年營運轉虧 今年拚重回成長軌道Anue鉅亨-2024/03/13
〈國光生展望〉子公司安特羅腸病毒三期臨床入尾聲 明年展開IPOAnue鉅亨-2023/12/26
〈國光生展望〉流感疫苗申請巴西藥證+破傷風切新市場 外銷業績拚成長Anue鉅亨-2023/12/26
國光生 相關文章